Validation of the integrated prediction model algorithm for outcome of cytoreduction in advanced ovarian cancer.

Authors

Sabrina Piedimonte

Sabrina Piedimonte

University Health Network, Toronto, ON, Canada

Sabrina Piedimonte , Marcus Bernardini , Sarah Ferguson , Stephane Laframboise , Genevieve Bouchard-Fortier , Paulina Cybulska , Lisa Avery , Taymaa May , Liat Frida Hogen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 5546)

DOI

10.1200/JCO.2022.40.16_suppl.5546

Abstract #

5546

Poster Bd #

425

Abstract Disclosures

Similar Posters

First Author: Giovanni Favero

Poster

2021 ASCO Annual Meeting

Does aggressive surgery only benefit patients with less advanced ovarian cancer?

Does aggressive surgery only benefit patients with less advanced ovarian cancer?

First Author: Shinichi Tate

Poster

2017 ASCO Annual Meeting

TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33 / AGO‐OVAR OP7).

TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33 / AGO‐OVAR OP7).

First Author: Sven Mahner

Poster

2015 ASCO Annual Meeting

Use of neoadjuvant chemotherapy in advanced ovarian cancer.

Use of neoadjuvant chemotherapy in advanced ovarian cancer.

First Author: Larissa Meyer